Clin2
NCT05010356Possibly a fitRecruiting

Testing insulin sensitivity after breast cancer treatment

Insulin Sensitivity/ResistanceBreast CancerSurvivorshipMetabolic Disturbance

Treatments studied

Part of Cancer, Hormones & metabolism, Skin clinical trials.

This study looks at how well your body uses insulin (a hormone that helps move sugar from the blood into cells) after breast cancer treatment. It may help researchers understand whether insulin sensitivity changes after chemotherapy and could guide future health monitoring.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
24 people
Ages
20 years to 45 years
Study type
Interventional

Who can take part

  • You are a premenopausal woman who had breast cancer surgery
  • You finished chemotherapy and at least 3 weeks have passed since it ended
  • Your body mass index (BMI) is between 25 and 30
  • You do not already have type 2 diabetes or metabolic syndrome being treated with medicine
  • You do not have known heart or blood vessel disease that needs medical treatment
  • You do not currently smoke and you drink no more than 7 alcoholic drinks per week

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07255807Recruiting
Understanding insulin resistance in healthy adults

This study will look at how insulin resistance works in the body by studying healthy adults. You may help researchers find new ways to understand and treat conditions like diabetes.

Copenhagen
NCT06261918Recruiting
Breast cancer study: linking metabolism to tumor behavior

This study looks at how your metabolism (things like blood sugar and cholesterol) might be linked to tumor genes and growth in people with breast cancer. The goal is to find new ways to treat the disease based on your metabolic profile. You may be eligible if you have locally advanced breast cancer (Stage II–III) and are willing to share your medical records.

Roma
NCT07405385Not yet recruiting
Exercise trial to restore metabolic health in breast cancer survivors

This trial tests if a combined exercise program can help restore metabolic flexibility in breast cancer survivors who recently finished chemotherapy. It may improve how your body uses energy and reduce long-term health risks.

Toledo, Toledo
NCT05989347Recruiting· Phase 1
Dapagliflozin with chemo for breast cancer

This trial tests whether adding the drug dapagliflozin (a pill that lowers blood sugar) to standard chemotherapy before breast cancer surgery can improve outcomes. It is for women with high insulin levels and a higher BMI who are about to start chemotherapy.

New Haven, Connecticut
NCT06633380Recruiting
Different physical activity strategies for breast cancer survivors

This study tests different ways to add physical activity into your daily routine to help manage side effects from breast cancer treatment. The goal is to see if simple, practical strategies can improve your health and well-being while you are on aromatase inhibitors.

Toronto, Ontario
NCT06454864Recruiting
Exercise and Diet for Breast Cancer Survivors

This study tests whether a 6-month program combining weekly supervised exercise and dietary advice can improve health in breast cancer survivors who have completed initial treatments. It aims to help with weight, heart health, and overall well-being.

Toronto, Ontario

Hear when a new Insulin Sensitivity/Resistance trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.